To begin exploring the translation potential of the endogenous p16INK4a mRNA we exploited polysomal profiling coupled to quantitative PCR in melanoma-derived SK-Mel-28 cells expressing p16 [28, 37]. This evidence concerns the gene CDKN2A and melanoma.